INT MEDICAL Stock Forum

Analyst sentiment dips with significant revenue estimate cuts and EPS reductions for Shanghai INT Medical Instruments. Despite downgrades, long-term valuation impact isn't expected, but reduced EPS hints at potential business challenges.